Beau Nakamoto is a Neurology physician affiliated with University of Hawaiʻi at Mānoa. OpenAlex indexes 70 publications with 1,727 citations (h-index 26); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
888 S King St
Honolulu, HI 968133009
Telephone
808-522-4000Registry record last updated 16 Mar 2012.
Clinical trials
- NP001, Alzheimer's Disease, and Blood Markers of Inflammation
Sponsor: Beau Nakamoto
- Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS
Sponsor: Beau Nakamoto
- Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders
Sponsor: University of Hawaii
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20251 payment
- UCB, Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
94.2%Other antiepileptics14.9%Levetiracetam39%Topiramate34%Topamax15%Lacosamide12%Part D<11 patientsCalcitonin gene-related peptide (CGRP) antagonists12.1%Aimovig Autoinjector81%Emgality Pen19%Part D<11 patients+ 12 more classes in this area
Musculoskeletal
2.5%Neuromuscular Blocker2.5%Botox100%Part D<11 patientsMetabolism & gastrointestinal
1.7%Corticosteroid1.7%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2015–2016 per NIH RePORTER. The latest:
- Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in NeuroAIDS
University of Hawaii at Manoa
FY2016$192,188R21NS087951 - Ferumoxytol-enhanced Imaging and Quantitative Susceptibility Mapping in NeuroAIDS
University of Hawaii at Manoa
FY2015$229,125R21NS087951
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Improved Cognitive Performance and Reduced Monocyte Activation in Virally Suppressed Chronic HIV After Dual CCR2 and CCR5 Antagonism
JAIDS Journal of Acquired Immune Deficiency Syndromes
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Cecilia Shikuma, MD
University of Hawaiʻi at Mānoa
Todd Seto, MD
University of Hawaiʻi at Mānoa
Brian Issell, MD, FACP
University of Hawaiʻi at Mānoa
Naoky Tsai, MD
University of Hawaiʻi at Mānoa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”